| Daniel Lee Kim, MD | |
|
132 Abigail Ln, Port Matilda, PA 16870-7153 | |
| (814) 272-5011 | |
| (814) 272-6531 |
| Full Name | Daniel Lee Kim |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 132 Abigail Ln, Port Matilda, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114986817 | NPI | - | NPPES |
| 02248355 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger-lewistown Hospital | Lewistown, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
In Arkansas, the House held off on a fifth vote for funding the state's "private option." The Maine compromise would expand Medicaid while also reforming the program.
Endo Pharmaceuticals (NASDAQ:ENDP) and Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) announced today that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash, and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that more than 12,000 courses of lung cancer treatment have been completed with CyberKnife radiosurgery. Usage of CyberKnife radiosurgery for lung cancer continues to grow, as illustrated by a 25 percent increase year over year in calendar year 2009.
The American Gastroenterological Association (AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry — which seeks to compare laparoscopic surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD) — have successfully undergone treatment.
Using a polymer coating designed to resemble the outer surface of a cell membrane, a team of investigators led by Steve Armes, Ph.D., of the University of Sheffield in the United Kingdom, has created a highly stable, biocompatible magnetic nanoparticle expected to improve the sensitivity of magnetic resonance imaging (MRI).
› Verified 9 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
In Arkansas, the House held off on a fifth vote for funding the state's "private option." The Maine compromise would expand Medicaid while also reforming the program.
Endo Pharmaceuticals (NASDAQ:ENDP) and Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) announced today that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash, and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that more than 12,000 courses of lung cancer treatment have been completed with CyberKnife radiosurgery. Usage of CyberKnife radiosurgery for lung cancer continues to grow, as illustrated by a 25 percent increase year over year in calendar year 2009.
The American Gastroenterological Association (AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry — which seeks to compare laparoscopic surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD) — have successfully undergone treatment.
Using a polymer coating designed to resemble the outer surface of a cell membrane, a team of investigators led by Steve Armes, Ph.D., of the University of Sheffield in the United Kingdom, has created a highly stable, biocompatible magnetic nanoparticle expected to improve the sensitivity of magnetic resonance imaging (MRI).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Lee Kim, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Daniel Lee Kim, MD 132 Abigail Ln, Port Matilda, PA 16870-7153 Ph: (814) 272-5011 |
News Archive
In Arkansas, the House held off on a fifth vote for funding the state's "private option." The Maine compromise would expand Medicaid while also reforming the program.
Endo Pharmaceuticals (NASDAQ:ENDP) and Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) announced today that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash, and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that more than 12,000 courses of lung cancer treatment have been completed with CyberKnife radiosurgery. Usage of CyberKnife radiosurgery for lung cancer continues to grow, as illustrated by a 25 percent increase year over year in calendar year 2009.
The American Gastroenterological Association (AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry — which seeks to compare laparoscopic surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD) — have successfully undergone treatment.
Using a polymer coating designed to resemble the outer surface of a cell membrane, a team of investigators led by Steve Armes, Ph.D., of the University of Sheffield in the United Kingdom, has created a highly stable, biocompatible magnetic nanoparticle expected to improve the sensitivity of magnetic resonance imaging (MRI).
› Verified 9 days ago
Sabrina Kum Whitehurst, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 132 Abigail Lane, Port Matilda, PA 16870 Phone: 814-272-7100 | |
Dr. Mary Catherine Kruszewski, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 132 Abigail Ln, Port Matilda, PA 16870 Phone: 814-272-7100 Fax: 814-272-6507 | |
Dr. Steven A Zeger, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 132 Abigail Lane, Port Matilda, PA 16870 Phone: 814-272-7100 Fax: 814-272-6501 | |
Dr. Samuel K. Owusu, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 132 Abigail Ln, Port Matilda, PA 16870 Phone: 814-272-7100 Fax: 814-272-6501 | |
Canan Sahin-kandemir, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 132 Abigail Ln, Port Matilda, PA 16870 Phone: 814-272-7200 Fax: 814-272-6501 | |
Sandhya Yerram, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 132 Abigail Ln, Port Matilda, PA 16870 Phone: 814-272-7100 Fax: 814-272-6501 |